There are 3397 resources available
IO and chemotherapy before or after surgery?
Presenter: Luis Paz-Ares
Session: Managing stage III NSCLC in the era of IO
Resources:
Slides
Webcast
A dermatologist’s perspective: Secondary prevention and risk stratifications strategies
Presenter: Dirk Schadendorf
Session: Early-stage (II/III) melanoma: Risk stratification and treatment decisions
Resources:
Slides
Webcast
Perioperative considerations and management of localised disease
Presenter: Margot Tesselaar
Session: Advances in our understanding of paraganglioma / pheochromocytoma
Resources:
Slides
Webcast
Interpretation of current peri-operative trial designs and endpoints
Presenter: Srikala Sridhar
Session: Neoadjuvant and adjuvant therapy in genitourinary cancers
Resources:
Slides
Webcast
Which patients need more intensive treatment?
Presenter: Jean Bourhis
Session: Intensification vs descalation of therapy in H&N cancer: When and for whom?
Resources:
Slides
Webcast
Investigator-initiated trials: From design to activation
Presenter: Nadia Harbeck
Session: YO Masterclass: Tackling new challenges facing young investigators
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: ESMO Clinical Practice Guidelines 2
Resources:
Slides
Webcast
Systemic anticancer therapy-related fatigue: Causes and management
Presenter: Christina Ruhlmann
Session: In collaboration with the MASCC - The multiple faces of fatigue in the cancer ecosystem
Resources:
Slides
Webcast
Fatigue related to emerging targeted anticancer therapeutics
Presenter: Hope Rugo
Session: In collaboration with the MASCC - The multiple faces of fatigue in the cancer ecosystem
Resources:
Slides
Webcast
Predicting response or resistance to IO
Presenter: Giampaolo Bianchini
Session: Finding the positive in triple negative breast cancer
Resources:
Slides
Webcast